Clinical Observation on chronic hepatitis B With low ALT Theated by interferon and yexiazhu
-
摘要: 目的探索叶下珠、干扰素α-2b(IFNα-2b)不同组方治疗慢性低酶型乙型肝炎的临床治疗效果。方法用叶下珠片治疗低酶型乙型肝炎152例,3个月内ALT升高达1000U/L以上者,随机分为叶下珠继续治疗组(Ⅱa组),加用IFNα-2b组(Ⅱb组),改用IFNα-2b组(Ⅱc组),仍属低酶者设为对照组(Ⅰ组)继续应用叶下珠,Ⅰ组、Ⅱ组所有患者在相同条件下,采用不同方案继续治疗6个月。结果Ⅱa、Ⅱb、Ⅱc组均在ALT复常,HBeAg阴转,抗-HBe阳转,HBVDNA阴转方面优于Ⅰ组(P<0.05);Ⅱb、Ⅱc组明显优于Ⅰ组(P<0.05);Ⅱb、Ⅱc之间无差异(P>0.05)。结论慢性低酶型乙型肝炎患者应用叶下珠初始治疗,在ALT升高达100U/L以上,适时加用或改用IFNα-2b治疗慢性乙型肝炎可获得满意的临床疗效。Abstract: Objective To investigate the effect of Yexiazhu (YXZ) combined with interferon α-2b in the the treatment of low ALT chronic hepatitis B.Methods 152 patients with low ALT chronic hepatitis B were given YXZ.When the biochemical response (ALT>100μ/L) appeared after 3months.The patients were randomly divided into four equal groups.The patients in combined treatment group were treated with YXZ and interferon α-2b, while patients in group Ⅱa.Ⅱb and Ⅱc treated only by YXZ or interferon α-2b, respectively for 6 months.Results The liver function tests and hepatitis B virus marker were observed.The combined response (HBeAg loss HBVDNA suppression and ALT normalization) to interferon α-2b in group Ⅱa.Ⅱb and Ⅱc show superior inefficacy with group Ⅰ (P<0.01) .Ⅱb and Ⅱc was no statistical difference (P>0.05) .Conclusions Compared with patients with chronic hepatitis B with interferon α-2b.the clinical efficacy of interferon in the retreatment of patients with chronic hepatitis B faiure to YXZ had statistically significance and the efficacy of long trem was more satisfactory.
-
Key words:
- Chronic Hepatitis B /
- interferon α-2b /
- low-ALT /
- yexiazhu /
- antirival therapy
-
[1] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (2) ∶324~329. [2]顾长海.慢性乙型肝炎干扰素疗法的适应症选择[J].中华肝脏病杂志, 2002, 10 (2) ∶139~142. [3]Klaus-Peter Maier. (郝连杰等译) .肝炎及其后果[M].第四版.北京:人民卫生出版社, 1997∶116~119. [4]叶维法, 钟振义.当代肝胆疾病治疗学[M].成都:四川科学技术出版社, 2000∶50~57. [5]杨小云, 李韶光, 温帆渊, 等.肝活检对转氨酶轻度升高的慢性乙型肝炎患者的临床意义[J].中西医结合肝病杂志, 2004, 10 (6) ∶42~43. [6]孙谢文, 马万科, 王玉华.叶下珠肝片与猪苓多糖、乙肝疫苗联合治疗慢性乙型肝炎47例[J].中西医结合肝病杂志, 2000, 10 (6) ∶42~43. [7]Bordens R, lrrossberg SE, Trotta PP, et al.Moleculer and bidogiccharacterization of recombinant interferonα2b[J].Seminaroncot, 1997, 24∶41~45.
计量
- 文章访问数: 2247
- HTML全文浏览量: 16
- PDF下载量: 770
- 被引次数: 0